Skip to main content
. 2021 Nov 15;11:650678. doi: 10.3389/fonc.2021.650678

Table 2.

Univariate and multivariate COX regression analysis of clinical factors and OLFML2B on overall survival of patients with bladder cancer.

Variables Univariate analysis Multivariate analysis
HR (95% CI) P HR (95% CI) P
TCGA-BLCA
Age 1.04(1.02-1.06) 3.69E-05 1.04(1.02-1.06) 1.66E-04
Gender 0.85(0.59-1.22) 3.74E-01 0.84(0.59-1.21) 3.60E-01
Grade 26257554.67(0-Inf) 9.95E-01 3539739.69(0-Inf) 9.92E-01
T stage 1.76(1.38-2.25) 6.40E-06 1.77(1.37-2.29) 1.61E-05
OLFML2B 1.15(1.04-1.27) 6.37E-03 1.08(0.98-1.2) 1.22E-01
GSE13507
Age 1.07(1.04-1.1) 4.53E-08 1.07(1.04-1.1) 3.07E-07
Gender 0.64(0.36-1.14) 1.29E-01 0.78(0.42-1.43) 4.19E-01
Grade 2.74(1.69-4.43) 4.00E-05 0.94(0.51-1.71) 8.33E-01
T stage 2.05(1.64-2.58) 5.06E-10 2.09(1.57-2.79) 4.78E-07
OLFML2B 1.65(1.24-2.2) 5.46E-04 1.03(0.72-1.48) 8.67E-01
E-MTAB-1803
Age 0.99(0.96-1.02) 6.83E-01 1(0.97-1.03) 8.35E-01
Gender 1.08(0.45-2.59) 8.63E-01 1.8(0.7-4.64) 2.23E-01
Grade 0.88(0.31-2.49) 8.12E-01 1.08(0.38-3.11) 8.84E-01
T stage 2.92(1.88-4.53) 1.74E-06 3.04(1.92-4.83) 2.34E-06
OLFML2B 1.31(0.97-1.75) 7.39E-02 1.4(1.02-1.92) 3.90E-02
GSE32548
Age 1.04(0.99-1.08) 9.34E-02 1.05(1.01-1.1) 2.82E-02
Gender 1.29(0.48-3.43) 6.13E-01 1.37(0.49-3.84) 5.50E-01
Grade 2.26(1.07-4.77) 3.26E-02 0.62(0.21-1.83) 3.85E-01
T stage 3.53(1.89-6.6) 7.42E-05 4.22(1.69-10.5) 1.98E-03
OLFML2B 2.19(1.48-3.24) 9.12E-05 1.47(0.9-2.41) 1.26E-01
GSE32894
Age 0.98(0.95-1.01) 1.79E-01 0.96(0.91-1.01) 8.44E-02
Gender 1.47(0.55-3.93) 4.45E-01 1.13(0.42-3.06) 8.14E-01
Grade 7.59(2.45-23.52) 4.45E-04 5.8(1.82-18.45) 2.91E-03
T stage 0.98(0.62-1.56) 9.42E-01 0.96(0.58-1.6) 8.87E-01
OLFML2B 2.06(1.49-2.86) 1.56E-05 1.62(1.11-2.35) 1.27E-02

HR, hazard ratio; CI, confidence interval; Inf, infinity.

Bold means p < 0.05.